Clinical Trial Results:
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Three-Treatment, Three 6-Week Period Cross-Over, Multi-Center Exploratory Study to Evaluate the Effect of Adding GSK2190915 300mg Tablets Once Daily, Montelukast 10mg Tablets Once Daily or Placebo Tablets Once Daily to Fluticasone Propionate 250mcg/Salmeterol 50mcg Inhalation Powder Twice Daily in Uncontrolled Asthmatic Subjects > 18 Years of Age.
Summary
|
|
EudraCT number |
2010-019989-91 |
Trial protocol |
BG |
Global completion date |
11 Oct 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
15 Feb 2016
|
First version publication date |
05 Nov 2014
|
Other versions |
|
Summary report(s) |
114387-Clinical-Study-Result-Summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.